Management of platelet-directed pharmacotherapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures

Richard C. Becker, James Scheiman, Harold L. Dauerman, Frederick Spencer, Sunil Rao, Marc Sabatine, David A. Johnson, Frances Chan, Neena Susan Abraham, Eamonn M M Quigley

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

The periprocedural management of patients with atherosclerotic coronary heart disease, including those who have heart disease and those who are undergoing percutaneous coronary intervention and stent placement who might require temporary interruption of platelet-directed pharmacotherapy for the purpose of an elective endoscopic gastrointestinal procedure, is a common clinical scenario in daily practice. Herein, we summarize the available information that can be employed for making management decisions and provide general guidance for risk assessment.

Original languageEnglish (US)
Pages (from-to)2903-2917
Number of pages15
JournalAmerican Journal of Gastroenterology
Volume104
Issue number12
DOIs
StatePublished - Dec 2009
Externally publishedYes

Fingerprint

Percutaneous Coronary Intervention
Stents
Coronary Disease
Coronary Artery Disease
Heart Diseases
Decision Making
Blood Platelets
Drug Therapy

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Management of platelet-directed pharmacotherapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures. / Becker, Richard C.; Scheiman, James; Dauerman, Harold L.; Spencer, Frederick; Rao, Sunil; Sabatine, Marc; Johnson, David A.; Chan, Frances; Abraham, Neena Susan; Quigley, Eamonn M M.

In: American Journal of Gastroenterology, Vol. 104, No. 12, 12.2009, p. 2903-2917.

Research output: Contribution to journalArticle

Becker, Richard C. ; Scheiman, James ; Dauerman, Harold L. ; Spencer, Frederick ; Rao, Sunil ; Sabatine, Marc ; Johnson, David A. ; Chan, Frances ; Abraham, Neena Susan ; Quigley, Eamonn M M. / Management of platelet-directed pharmacotherapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures. In: American Journal of Gastroenterology. 2009 ; Vol. 104, No. 12. pp. 2903-2917.
@article{256138c9c1a74933ae5439fd2d9035cd,
title = "Management of platelet-directed pharmacotherapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures",
abstract = "The periprocedural management of patients with atherosclerotic coronary heart disease, including those who have heart disease and those who are undergoing percutaneous coronary intervention and stent placement who might require temporary interruption of platelet-directed pharmacotherapy for the purpose of an elective endoscopic gastrointestinal procedure, is a common clinical scenario in daily practice. Herein, we summarize the available information that can be employed for making management decisions and provide general guidance for risk assessment.",
author = "Becker, {Richard C.} and James Scheiman and Dauerman, {Harold L.} and Frederick Spencer and Sunil Rao and Marc Sabatine and Johnson, {David A.} and Frances Chan and Abraham, {Neena Susan} and Quigley, {Eamonn M M}",
year = "2009",
month = "12",
doi = "10.1038/ajg.2009.667",
language = "English (US)",
volume = "104",
pages = "2903--2917",
journal = "American Journal of Gastroenterology",
issn = "0002-9270",
publisher = "Nature Publishing Group",
number = "12",

}

TY - JOUR

T1 - Management of platelet-directed pharmacotherapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures

AU - Becker, Richard C.

AU - Scheiman, James

AU - Dauerman, Harold L.

AU - Spencer, Frederick

AU - Rao, Sunil

AU - Sabatine, Marc

AU - Johnson, David A.

AU - Chan, Frances

AU - Abraham, Neena Susan

AU - Quigley, Eamonn M M

PY - 2009/12

Y1 - 2009/12

N2 - The periprocedural management of patients with atherosclerotic coronary heart disease, including those who have heart disease and those who are undergoing percutaneous coronary intervention and stent placement who might require temporary interruption of platelet-directed pharmacotherapy for the purpose of an elective endoscopic gastrointestinal procedure, is a common clinical scenario in daily practice. Herein, we summarize the available information that can be employed for making management decisions and provide general guidance for risk assessment.

AB - The periprocedural management of patients with atherosclerotic coronary heart disease, including those who have heart disease and those who are undergoing percutaneous coronary intervention and stent placement who might require temporary interruption of platelet-directed pharmacotherapy for the purpose of an elective endoscopic gastrointestinal procedure, is a common clinical scenario in daily practice. Herein, we summarize the available information that can be employed for making management decisions and provide general guidance for risk assessment.

UR - http://www.scopus.com/inward/record.url?scp=72949118284&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=72949118284&partnerID=8YFLogxK

U2 - 10.1038/ajg.2009.667

DO - 10.1038/ajg.2009.667

M3 - Article

C2 - 19935784

AN - SCOPUS:72949118284

VL - 104

SP - 2903

EP - 2917

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

SN - 0002-9270

IS - 12

ER -